Week Ending November 8, 2021

Movement is Life-Optimizing Patient Access to Total Joint Arthroplasty: HIV and Hepatitis C Disparities
“This article is one of a series focusing on how the preoperative optimization process, if designed for underserved communities, can improve access to care and reduce disparities. In this article, we specifically focus on methods to improve optimization for patients with HIV and hepatitis C to facilitate their access to total joint arthroplasty.”

Chronic hepatitis C is expensive for Ontario patients and caregivers
“Using survey results from 275 patients, the study analyzed the financial burden of chronic hepatitis C (CHC) on patients treated in hospital and community clinics.”

What to know about hepatitis C and liver transplants
“Hepatitis C-related complications are a leading cause of liver transplants in the United States. A liver transplant is a life-saving surgery where a surgeon removes a diseased liver and replaces it with a healthy liver from a living or deceased donor.”

Liver Disease Linked to Higher Rate of Cardiovascular Disease
“Patients with liver disease had a twofold higher incidence of cardiovascular disease (CVD) than those without liver disease, with notable geographical variations, in an observational study.”

SVR and hepatitis C: A guide
“Sustained virologic response (SVR) can indicate that treatment for hepatitis C virus (HCV) has been successful. In most cases, having SVR means a person’s liver will no longer become damaged by HCV.”

What is the connection between hepatitis C and kidney damage?
“The hepatitis C virus can cause renal disease, though it is rare. It occurs when there is inflammation in the small blood vessels that usually act as filters inside the kidneys. Long-term damage can result, which may lead to the need for a transplant.”

Europe far from achieving hepatitis C elimination targets
“European Union states are far from reaching the global targets towards hepatitis C elimination, especially on harm reduction, testing and treatment, Dr Erika Duffell of the European Centre for Disease Control (ECDC) told the 18th European AIDS Conference (EACS 2021) last week.”

Most People With Cirrhosis Don’t Receive Recommended Monitoring
“Rates of regular monitoring for hepatocellular carcinoma and other liver complications in people with cirrhosis are inadequate, according to findings published in the Journal of Hepatology.”